QQQ   352.52 (+1.30%)
AAPL   179.96 (+1.53%)
MSFT   331.74 (+1.02%)
META   273.76 (+3.41%)
GOOGL   123.47 (+0.49%)
AMZN   123.35 (+2.30%)
TSLA   208.31 (+2.15%)
NVDA   399.09 (+5.48%)
NIO   7.60 (+0.93%)
BABA   83.98 (+5.57%)
AMD   120.73 (+2.13%)
T   15.79 (+0.38%)
F   12.12 (+1.00%)
MU   69.27 (+1.57%)
CGC   0.84 (+0.11%)
GE   104.97 (+3.39%)
DIS   88.65 (+0.78%)
AMC   4.63 (+2.89%)
PFE   37.97 (-0.13%)
PYPL   63.17 (+1.90%)
NFLX   403.84 (+2.18%)
QQQ   352.52 (+1.30%)
AAPL   179.96 (+1.53%)
MSFT   331.74 (+1.02%)
META   273.76 (+3.41%)
GOOGL   123.47 (+0.49%)
AMZN   123.35 (+2.30%)
TSLA   208.31 (+2.15%)
NVDA   399.09 (+5.48%)
NIO   7.60 (+0.93%)
BABA   83.98 (+5.57%)
AMD   120.73 (+2.13%)
T   15.79 (+0.38%)
F   12.12 (+1.00%)
MU   69.27 (+1.57%)
CGC   0.84 (+0.11%)
GE   104.97 (+3.39%)
DIS   88.65 (+0.78%)
AMC   4.63 (+2.89%)
PFE   37.97 (-0.13%)
PYPL   63.17 (+1.90%)
NFLX   403.84 (+2.18%)
QQQ   352.52 (+1.30%)
AAPL   179.96 (+1.53%)
MSFT   331.74 (+1.02%)
META   273.76 (+3.41%)
GOOGL   123.47 (+0.49%)
AMZN   123.35 (+2.30%)
TSLA   208.31 (+2.15%)
NVDA   399.09 (+5.48%)
NIO   7.60 (+0.93%)
BABA   83.98 (+5.57%)
AMD   120.73 (+2.13%)
T   15.79 (+0.38%)
F   12.12 (+1.00%)
MU   69.27 (+1.57%)
CGC   0.84 (+0.11%)
GE   104.97 (+3.39%)
DIS   88.65 (+0.78%)
AMC   4.63 (+2.89%)
PFE   37.97 (-0.13%)
PYPL   63.17 (+1.90%)
NFLX   403.84 (+2.18%)
QQQ   352.52 (+1.30%)
AAPL   179.96 (+1.53%)
MSFT   331.74 (+1.02%)
META   273.76 (+3.41%)
GOOGL   123.47 (+0.49%)
AMZN   123.35 (+2.30%)
TSLA   208.31 (+2.15%)
NVDA   399.09 (+5.48%)
NIO   7.60 (+0.93%)
BABA   83.98 (+5.57%)
AMD   120.73 (+2.13%)
T   15.79 (+0.38%)
F   12.12 (+1.00%)
MU   69.27 (+1.57%)
CGC   0.84 (+0.11%)
GE   104.97 (+3.39%)
DIS   88.65 (+0.78%)
AMC   4.63 (+2.89%)
PFE   37.97 (-0.13%)
PYPL   63.17 (+1.90%)
NFLX   403.84 (+2.18%)
NASDAQ:ASRT

Assertio (ASRT) Stock Forecast, Price & News

$6.43
+0.10 (+1.58%)
(As of 02:15 PM ET)
Compare
Today's Range
$6.28
$6.56
50-Day Range
$5.00
$7.66
52-Week Range
$2.07
$8.01
Volume
647,800 shs
Average Volume
2.04 million shs
Market Capitalization
$358.15 million
P/E Ratio
4.26
Dividend Yield
N/A
Price Target
$9.50

Assertio MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
46.8% Upside
$9.50 Price Target
Short Interest
Bearish
17.79% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$910,646 Sold Last Quarter
Proj. Earnings Growth
83.33%
From $0.36 to $0.66 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.35 out of 5 stars

Medical Sector

347th out of 1,980 stocks

Pharmaceutical Preparations Industry

137th out of 978 stocks


ASRT stock logo

About Assertio (NASDAQ:ASRT) Stock

Assertio Holdings, Inc. engages in the provision of commercial pharmaceutical products. Its commercial portfolio of branded products focuses on the following areas: neurology, hospital, and pain and inflammation. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Receive ASRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Assertio and its competitors with MarketBeat's FREE daily newsletter.

ASRT Stock News Headlines

Graphite versus Lithium - What Investors Should Know
Over 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.
Assertio (NASDAQ:ASRT) Downgraded by StockNews.com to Hold
AI is Unstoppable. Now Is The Time!
AI, or Artificial Intelligence, is all the rage right now. AI technologies are empowering users in every industry to increase sales, efficiency, and productivity. It's truly a case of adapt or fail.
Recap: Assertio Holdings Q1 Earnings
Assertio: Q1 Earnings Snapshot
Assertio (NASDAQ: ASRT)
See More Headlines

ASRT Price History

ASRT Company Calendar

Last Earnings
3/08/2023
Today
6/01/2023
Next Earnings (Estimated)
8/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ASRT
Employees
19
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.50
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+47.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$109.63 million
Pretax Margin
9.74%

Debt

Sales & Book Value

Annual Sales
$156.23 million
Cash Flow
$2.96 per share
Book Value
$4.50 per share

Miscellaneous

Free Float
51,300,000
Market Cap
$359.82 million
Optionable
Optionable
Beta
1.39

Key Executives

  • Daniel A. PeisertDaniel A. Peisert
    President, Chief Executive Officer & Director
  • William Iskos
    Senior Vice President-Operations
  • Paul SchwichtenbergPaul Schwichtenberg
    Chief Financial Officer & Senior Vice President
  • Howard J. Franklin
    Senior Vice President-Medical
  • Ajay PatelAjay Patel
    Chief Accounting Officer & Senior Vice President













ASRT Stock - Frequently Asked Questions

Should I buy or sell Assertio stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Assertio in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ASRT shares.
View ASRT analyst ratings
or view top-rated stocks.

What is Assertio's stock price forecast for 2023?

3 Wall Street research analysts have issued 1 year target prices for Assertio's stock. Their ASRT share price forecasts range from $9.00 to $10.00. On average, they anticipate the company's stock price to reach $9.50 in the next year. This suggests a possible upside of 47.1% from the stock's current price.
View analysts price targets for ASRT
or view top-rated stocks among Wall Street analysts.

How have ASRT shares performed in 2023?

Assertio's stock was trading at $4.30 at the beginning of the year. Since then, ASRT shares have increased by 50.2% and is now trading at $6.46.
View the best growth stocks for 2023 here
.

When is Assertio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our ASRT earnings forecast
.

How were Assertio's earnings last quarter?

Assertio Holdings, Inc. (NASDAQ:ASRT) released its earnings results on Wednesday, March, 8th. The company reported $1.34 earnings per share for the quarter, topping the consensus estimate of $0.23 by $1.11. The company had revenue of $50.35 million for the quarter, compared to analyst estimates of $49.57 million. Assertio had a trailing twelve-month return on equity of 52.50% and a net margin of 59.86%.

What ETFs hold Assertio's stock?

ETFs with the largest weight of Assertio (NASDAQ:ASRT) stock in their portfolio include Hartford Multifactor Small Cap ETF (ROSC).Barrons 400 ETF (BFOR).

What guidance has Assertio issued on next quarter's earnings?

Assertio updated its first quarter 2023 earnings guidance on Wednesday, March, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $36.00 million-$38.00 million, compared to the consensus revenue estimate of $37.59 million.

What other stocks do shareholders of Assertio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Assertio investors own include Sorrento Therapeutics (SRNE), Actinium Pharmaceuticals (ATNM), T2 Biosystems (TTOO), VBI Vaccines (VBIV), InterDigital (IDCC), Trevena (TRVN), Ampio Pharmaceuticals (AMPE), Bionano Genomics (BNGO), Cerecor (CERC) and OPKO Health (OPK).

What is Assertio's stock symbol?

Assertio trades on the NASDAQ under the ticker symbol "ASRT."

Who are Assertio's major shareholders?

Assertio's stock is owned by a number of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (3.62%), Acadian Asset Management LLC (2.07%), BlackRock Inc. (1.73%), American Century Companies Inc. (1.16%), Two Sigma Investments LP (1.16%) and Arrowstreet Capital Limited Partnership (1.07%). Insiders that own company stock include Ajay Patel, Daniel A Peisert, Group LP Cr, Heather L Mason, James L Tyree and Paul Schwichtenberg.
View institutional ownership trends
.

How do I buy shares of Assertio?

Shares of ASRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Assertio's stock price today?

One share of ASRT stock can currently be purchased for approximately $6.46.

How much money does Assertio make?

Assertio (NASDAQ:ASRT) has a market capitalization of $359.82 million and generates $156.23 million in revenue each year. The company earns $109.63 million in net income (profit) each year or $1.51 on an earnings per share basis.

How can I contact Assertio?

Assertio's mailing address is 100 South Saunders Road Suite 300, Lake Forest IL, 60045. The official website for the company is www.assertiotx.com. The company can be reached via phone at (224) 419-7106, via email at investor@assertiotx.com, or via fax at 510-744-8001.

This page (NASDAQ:ASRT) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -